Yale Cancer Center

🧪58% early career phys-sci considering leaving research 📉72% cite $ instability as major driver 🌎43.9% considering leaving US for research abroad 🔥Burnout,⬇️research⏲️➡️attrition. Proud to partner w/@theNAMedicine for new phy-sci initiative tinyurl.com/479jt88j @AbushoukMD

Join us June 23 + 24 for a 2-part CME webinar series: 'Primary Care at the Center: Advancing Lung Screening Uptake:' 🫁Part 1: Tues., June 23 at 5:30pm> Expert presentations on lung screening eligibility, improving uptake, & engaging patients in #lungcancer screening 🫁Part 2: Wed., June 24 at 12pm> Patient navigation panel discussion ➡️RSVP: bit.ly/4f2M6KS @SmilowCancer @YaleThoracic

.@MaxStahlMD returns to #YaleCancerAnswers tonight at 7:30pm to continue his discussion on #leukemia, sharing exciting advancements in treatment options. 🎧 Listen live @wnpr 🔁 Download @ApplePodcasts 💻 Listen later @YouTube @SmilowCancer @YaleHematology

Congratulations to Markus Müschen, MD, PhD, @MuschenLab named a recipient of a 2026 Harrington Scholar Innovator Award by the @HarringtonDI_UH for his research: 'Drugging a Key Enzyme to Treat Immune Cell Cancers.’ news.uhhospitals.org/news-releases/… @SmilowCancer @YaleHematology @YaleIBIO

Congratulations to @DrSibaHaykal, 2026 recipient of the #HealthnetworkFoundation Service Excellence Award. Dr. Haykal received this honor based on feedback from grateful patients and supporters. medicine.yale.edu/surgery/news-a… @SmilowCancer @YalePlastics

Dr. Michael Cecchini @Cecchini_OncMD presented #GrandRounds on advanced #gastrointestinalcancers and Yale's role in developing novel therapeutic and biomarker strategies. #colorectalcancer #crc. Watch his full talk at youtube.com/watch?v=iD6KAQ… @SmilowCancer @YaleGICancers

The @taaforg 2026 Heritage Month Summit celebrated Asian excellence, resilience & leadership across tech, sports, media, arts, entrepreneurship. Raising visibility for the need for AAPI inclusion & leadership in biomedical research & medicine. Honor to be invited! 🌎✨

Today at 12pm, Dr. Michael Cecchini @Cecchini_OncMD joins #GrandRounds to present "Advanced #GastrointestinalCancers in 2026: A Focus on #ColorectalCancer and Yale's Role in Developing Novel Therapeutic and Biomarker Strategies." Watch in-person in Smilow Auditorium or online: bit.ly/4tADONO. @SmilowCancer @YaleGICancers

Study from @Nelson_LaMarche, PhD, Assistant Professor of Pathology @YaleMed, maps brain immune cells to block #melanoma metastasis, in this article published in @neurosciencenew. #skincancer @YaleCancer @YaleWestCampus tinyurl.com/2vyd4sst

Tonight at 7:30pm, @kturaga joins #YaleCancerAnswers to discuss the evolution of surgery in #cancer treatment, including robotic and laparoscopic surgery, and #AI. 🎧Listen live @wnpr 🔁Download @ApplePodcasts 💻Listen later @YouTube @SmilowCancer @YaleGICancers

.@ABidikianMD is presenting "Reversal of Systemic Mastocytosis-Induced Liver Cirrhosis with Avapritinib Treatment" at the American Initiative in #MastCell Diseases #AIM 2026 Physician and Investigator Conference today! @SmilowCancer @YaleHematology @YaleDigestive @yalepathology

.@maryam_lustberg presents this morning at 11:10am at #ESMOUSA in Focus: Breast Cancer East, a 1-day program delivering exclusive US-based updates from the 2026 @myESMO #BreastCancer Annual Congress. totalhealthoncology.com/upcoming-oncol… @SmilowCancer @YaleBreast @myESMO #ESMO26 @TotalHealthConf

What a day! The FDA has now approved the combination of oral decitabine/venetoclax for newly diagnosed older/unfit #AMLsm patients based on the ASCERTAIN V trial which I had the pleasure to present in #ASCO2025 on behalf of the investigators. It was unheard of to treat AML patients with just 2 oral pills, and to see several of our patients some of whom are in their 80s achieve long lasting remissions and be completely outpatient for more than 2 years is really gratifying, especially when you think the average survival of these patients a decade ago was less than few months. There is nothing better in clinical research that knowing that the drugs you helped get approved will not only help your own patients but will also hopefully help thousands of other patients who you will never meet.

Research from @Escobar_Lab + team identified a metabolic vulnerability in an aggressive subtype of #pancreaticcancer. Targeting the #K17-driven pathway improved chemotherapy response and doubled survival in preclinical models. aacrjournals.org/cancerres/arti… @SmilowCancer @CR_AACR

Join Barbara Burtness, MD, and @AartiBhatiaMD at #ASCO26 for a @PeerView live symposium on advances in #HNSCC, including immunotherapy and emerging treatments in LA and R/M disease. Join in-person in Chicago or virtually on May 29 at 7pm CDT/8pm EDT: bit.ly/2026HNC-T @SmilowCancer

A drug currently used to treat late-stage #breastcancer may offer new hope for patients with treatment-resistant #uterinecancer, according to new research from Yale. In a Phase II trial, more than 70% of patients saw tumor shrinkage overall. medicine.yale.edu/cancer/news-ar… @SmilowCancer @CCR_AACR @YaleObGynRes

A study from @RachelPerryLab1 in @PNASNews shows that working muscles can outcompete tumors for glucose, slowing their growth. The findings also suggest that exercise may play a role in the prevention and treatment of #cancer. medicine.yale.edu/cancer/news-ar… @SmilowCancer

A team of @YaleMed researchers - @Nelson_LaMarche, PhD, Harriet Kluger, MD & Lucia Jilaveanu, MD, PhD - believe the key to stopping #melanoma from spreading to the brain lies in the brain's immune system, not in the tumor. A @DeptofWar grant will support their work. @YaleCancer @YaleWestCampus bit.ly/3PDJw3u

Honored to be @GoldHouseCo Gold Gala/Founders party: AAPI excellence on full display✨From EJAE→@nguyen_amanda→@JLin7→@ChloeKim, rooms like this remind you what’s possible. Health is wealth. Yet Asians are underrepresented in biomed research. Let’s turn visibility→action.🚀

Researchers at Yale have developed #CanSys, an open-access tool that maps the genetic “fingerprints” of tumors to better predict #cancer risk and tumor behavior by analyzing both inherited and acquired DNA changes. medicine.yale.edu/cancer/news-ar… @SmilowCancer @GenomeMedicine